Sign in
BBTX Stock Price, Chart, Stats & News
Bambusa Therapeutics Inc.
Save
Bambusa Therapeutics Inc. (BBTX) does not currently pay a dividend.
842.97M
Market cap
–
Current P/E
–
Forward P/E
BBTX chart
Price history is unavailable
We don't have enough price data for BBTX to draw a chart yet.
About
Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases. The company was founded by Shan Shan Xu, Thang Ho, and Helmut Jeggle on March 14, 2024 and is headquartered in Boston, MA.
Similar securities
Based on sector and market capitalization
Report issue